-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Incyte, Raises Price Target to $113

Benzinga·06/26/2026 18:25:56
Listen to the news
UBS analyst Ashwani Verma maintains Incyte (NASDAQ:INCY) with a Neutral and raises the price target from $103 to $113.